Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2016
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Amanda J Walker, Suparna Wedam, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2015
FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Julia A Beaver, Laleh Amiri-Kordestani, Rosane Charlab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2015
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Geoffrey Kim, Gwynn Ison, Amy E McKee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs
Gwynn Ison, Julia A Beaver, W David McGuinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
Harpreet Singh, Michael Brave, Julia A Beaver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation
Geoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 6, 2012
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary
Katherine Thornton, Geoffrey Kim, V Ellen Maher, et al.
JAMA Network Open
|
April 12, 2024
Remote Monitoring and Data Collection for Decentralized Clinical Trials
Bobby Daly, Otis W Brawley, Mary K Gospodarowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation-Associated Advanced Ovarian Cancer
Sanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2016
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Amanda J Walker, Suparna Wedam, Laleh Amiri-Kordestani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2015
FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Julia A Beaver, Laleh Amiri-Kordestani, Rosane Charlab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2015
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Geoffrey Kim, Gwynn Ison, Amy E McKee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs
Gwynn Ison, Julia A Beaver, W David McGuinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
Harpreet Singh, Michael Brave, Julia A Beaver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation
Geoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 6, 2012
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary
Katherine Thornton, Geoffrey Kim, V Ellen Maher, et al.
JAMA Network Open
|
April 12, 2024
Remote Monitoring and Data Collection for Decentralized Clinical Trials
Bobby Daly, Otis W Brawley, Mary K Gospodarowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation-Associated Advanced Ovarian Cancer
Sanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, et al.
Page
of 3